AGENERASE

LOE Approaching

amprenavir

NDAORALSOLUTION
Approved
Apr 1999
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
17

Clinical Trials (5)

NCT01290211Phase 1Completed

Pharmacokinetic Interaction Between Maraviroc And Fosamprenavir/Ritonavir In Healthy Subjects

Started Apr 2011
28 enrolled
Healthy
NCT01209065Phase 1Completed

GSK1349572 Drug Interaction Study With Fosamprenavir/Ritonavir

Started Sep 2010
27 enrolled
Infections, Human Immunodeficiency Virus and Herpesviridae
NCT01140412Phase 1Terminated

Pharmacokinetic Interaction Between Maraviroc And Fosamprenavir/Ritonavir In Healthy Subjects

Started Jul 2010
14 enrolled
Healthy
NCT00977301Phase 1Completed

Interaction Between Fosamprenavir/Ritonavir and a Single-dose Olanzapine (FORZA)

Started Nov 2009
24 enrolled
HIV Infections
NCT01054586N/ACompleted

Fosamprenavir in Pts With Hepatic Impairment

Started Jan 2009
167 enrolled
Infection, Human Immunodeficiency Virus